Recipharm's biotech subsidiary, Recipharm Biotech, has acquired AstraZeneca's biotech manufacturing facility in Södertälje, Sweden. AstraZeneca has entered a supply arrangement with Recipharm for Phase I and Phase II material for one of its development projects and will hold a significant minority stake in the new company.
Recipharm
Tuesday, 18 November 2008
Recipharm moves into biologics manufacturing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment